| 产品详情 |
| Edit |   |
|---|
| Product Name | Bischloroanthrabenzoxocinone |
|---|
| Description | Purity >99%. Bacterial type II fatty acid synthesis (FAS-II) is mediated by a series of enzymes, each of which may be targeted by potential antibiotics. Bischloroanthrabenzoxocinone (BABX) is an inhibitor of FAS-II, blocking fatty acid synthesis in S. aureus and E. coli with IC50 values of 11.4 and 35.3 µg/ml, respectively. It inhibits the growth of S. aureus and permeable E. coli strains with minimum inhibitory concentrations ranging from 0.2-0.4 µg/ml. BABX also displays binding to liver X receptors (LXRs), inhibiting agonist binding in an LXRAlpha-scintillation proximity assay (IC50 = 10 µM). |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (6R,16R)-10,12-dichloro-6,7,9,16-tetrahydro-11,13,15-trihydroxy-3-methoxy-1,6,9,9-tetramethyl-6,16-epoxy-14H-anthra[2,3-d][1]benzoxocin-14-one, (-)-Bischloroanthrabenzoxocinone, BABX |
|---|
| Gene, Accession, CAS # | CAS: 866022-28-8 |
|---|
| Catalog # | LS-H10696 |
|---|
| Price | |
|---|
| Order / More Info | Bischloroanthrabenzoxocinone from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|